The investigation by The Schall Law Firm into Medpace Holdings, Inc. for potential securities law violations suggests that the company may have issued misleading statements or failed to disclose important information. This could lead to legal consequences and negatively impact investor confidence, potentially causing a short-term decline in the stock price.